FindTrial
Sign In

Effect of different doses of ropivacaine on transmuscular quadratus lumborum block in radical gastrectomy for gastric cancer

Clinical application of ultrasound-guided transmuscular quadratus lumborum block with subcostal approach combined with patient-controlled intravenous analgesia of nabocone

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900021175
Enrollment
Unknown
Registered
2019-01-31
Start date
2019-03-01
Completion date
Unknown
Last updated
2019-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative analgesia

Interventions

Group 1:2mg/kg ropivacaine
Group 2:2.5mg/kg ropivacaine
Group 3:3mg/kg ropivacaine
Group 4:3mg/kg ropivacaine

Sponsors

Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with gastric cancer undergoing radical gastrectomy; 2. Aged 20 to 65 years; 3. Weight 40-75 kg; 4. BMI 18-28 kg/m2; 5. ASA grade I to II; 6. Informed consent signed by patients.

Exclusion criteria

Exclusion criteria: 1. Allergy to local anesthetics; 2. Allergy to opioids; 3. Severe coagulation dysfunction, liver and kidney dysfunction; 4. Severe heart and lung diseases.

Design outcomes

Primary

MeasureTime frame
Visual analog pain score ( VAS);PCIA pressing frequency;Consumption of remifentanil;—

Secondary

MeasureTime frame
Adverse reaction;Vital signs;—

Countries

China

Contacts

Public ContactNie Bingqing

Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology

niebingqing1986@163.com+86 13971267447

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026